Mellozzan (melatonin) is now Reimbursed
The Swedish Dental and Pharmaceutical Benefits Agency (TLV) has today decided that Mellozzan (melatonin) tablets 0.5mg, 1mg, 2mg, 3mg, 4mg, 5mg should be included in the pharmaceutical benefit (reimbursement) system with a limitation to the indication "Insomnia in children and adolescents 6 - 17 years with ADHD where sleep hygiene measures have been insufficient”.5-7% of children and young people in Sweden have ADHD according to the National Board of Health and Welfare, and the incidence of children with sleep difficulties (insomnia) is very high, up to 80%, among these. The result is a